NEWS 80 FEED & ADDITIVE MAGAZINE November 2024 A new study by the Research Laboratory in Canine Nutrition (LENUCAN) at the Federal University of Parana (UFPR) in Brazil found that Enifer’s PEKILO®Pet mycoprotein ingredient enhances dog health by increasing the prevalence of potentially probiotic bacterial genera and decreasing the prevalence of bacterial genera associated with certain cancers, as well as increasing the production of short-chain fatty acids (SFCAs). The study also found that diets containing 20% PEKILO®Pet had a high protein digestibility of 83.9%, highlighting the potential of this upcycled mycoprotein as a sustainable and nutrient-rich ingredient for pet food. The 42-day study of 16 oneyear-old beagles (eight male, eight female), with an average weight of 10.43kg and inclusion rates of 4, 8, 12, 16, and 20 percent, found statistically significant increases in gut microbiome diversity with PEKILO®Pet inclusion in their diet. Even using the smallest inclusion rate (4%), PEKILO®Pet increased the health-beneficial microbes in the dog’s gut and decreased harmful bacteria. Previous research shows that the gut plays an important role in animal health. In particular, the microbiome in the gut is known to affect both the absorption and metabolism of nutrients and the dog’s protective functions. Probiotics have beneficial effects on pets, such as modulating the immune system, helping to reduce stress, protecting against pathogenic bacteria, and supporting healthy growth. “Our findings confirm that even at low inclusion levels, PEKILO®Pet enhances beneficial gut bacteria while reducing harmful ones, which could have far-reaching health benefits for dogs, from improved digestion to enhanced immune function,” says Heikki Keskitalo, Business Development Manager and Co-Founder of Enifer. Read more>> Spanish biotechnology company Tebrio successfully closed a €30 million funding round. Investors in this round include Banco de Santander, Sodical Instituto Financiero de Castilla y León, GCP, and the CDTI Innvierte Economía Sostenible closed-end collective investment company. Tebrio, one of the global leaders in the industrial production of Tenebrio molitor, explains it will allocate the capital raised from this funding round to significantly increase its production capacity and optimization at its new 90,000 square meter facility. Construction is already underway in Salamanca, Spain. With this new plant, Tebrio will be able to produce over 100,000 tons of product annually, meeting the high levels of production and commercialization demand already committed to its current clients. "This new round of investment in our company validates our industrial model based on proprietary technology. A model that allows us to produce at competitive prices in the markets where we operate, thus serving as a platform to expand our operations to different geographic markets," highlights Adriana Casillas, CEO and Co-Founder of Tebrio, a company that also maintains Caixa Capital Risc as a shareholder. Read more>> New study suggests fungal protein improves gut health and digestion in dogs Biotechnology start-up secures €30 million in funding
RkJQdWJsaXNoZXIy MTUxNjkxNQ==